Perimenopause Cramps and Pelvic Pain: Why They Change, and When They Need Evaluation

The short answer

Cramping without a period is not a paradox. You can ovulate without bleeding, bleed without ovulating, and have a cycle where the lining primes, the uterus contracts on schedule, and no visible period arrives. Mid-cycle ovulation pain, a fibroid pressing on neighboring structures, adenomyosis that aches independent of bleeding, or pelvic floor muscles that have started guarding around chronic pain — none of these need a period to hurt. ACOG describes irregular cycles and shifting bleeding patterns as expected features of the menopause transition, which is exactly why the useful question is not "is this normal?" but "which pattern is this?"

The line that matters clinically is between primary dysmenorrhea — pain from normal prostaglandin-driven contractions, typically beginning in adolescence — and secondary dysmenorrhea, pain caused by an underlying condition. ACOG's dysmenorrhea guidance draws this distinction directly, and it is the distinction that midlife pain most often gets wrong. Pain that is new in your 40s, worsening year over year, one-sided, present between periods, or paired with bleeding changes is secondary until proven otherwise. That deserves an exam and usually imaging, not a decade of ibuprofen and the phrase "it's just perimenopause."

Why perimenopausal cycles turn erratic — and why that changes cramping

In a regular reproductive-age cycle, an ovarian follicle matures, ovulation occurs, and the corpus luteum produces progesterone for a predictable luteal phase. That progesterone stabilizes the endometrium and then withdraws on schedule, producing a period of fairly consistent volume and timing. Perimenopause dismantles that rhythm. The pool of remaining follicles shrinks and responds unevenly to pituitary signaling, so some cycles produce a strong estrogen surge and no ovulation at all, others ovulate early, and others ovulate with a short or inadequate luteal phase.

The cramping consequence follows from the lining. When ovulation does not occur, there is no progesterone to organize and limit endometrial growth, so estrogen builds the lining unopposed. When that lining eventually breaks down, it sheds as a heavier, more disorganized bleed. Heavier shedding means more prostaglandin release, more clot formation, and a uterus working harder to expel volume — which is felt as stronger, more sustained cramping, often with clots and sometimes with back and thigh pain.

The reverse pattern also appears: cycles that shorten for a stretch, which means cramping arrives more frequently even if each episode is unchanged in intensity. Many women describe this as "cramping all the time" when what has actually happened is that the intervals between cramping episodes collapsed.

ACOG's patient guidance on the menopause years frames irregular periods as the defining feature of the transition rather than an aberration. The clinical point is that irregularity itself is expected — but pain severity is not part of that expectation. "Your cycles are irregular" explains a changed schedule. It does not explain pain that has sharply intensified.

Cramps without a period: what is actually happening

Menstrual-type cramping in a month with no bleeding usually traces to one of a handful of mechanisms, and distinguishing them matters because two of them need evaluation.

Ovulation pain (mittelschmerz) is felt as a one-sided ache or sharp twinge, usually short-lived, as a follicle ruptures and releases fluid that irritates the peritoneum. In perimenopause it can feel more pronounced than it used to, partly because follicular recruitment becomes less orderly. The side can vary from cycle to cycle, and it should settle on its own.

An anovulatory cycle can still generate cramping without producing a visible bleed: the endometrium responds to hormonal cues and the myometrium contracts, but shedding does not reach the threshold of noticeable bleeding, or shows up only as spotting days later. This is one of the most common explanations for "cramps but no period" in the 40s.

Structural causes are period-independent by nature. Adenomyosis — endometrial tissue growing within the uterine muscle wall — produces deep, diffuse aching that often starts days before any bleeding and can persist through the whole month. Fibroids produce pressure, heaviness, and cramping determined by their size and location rather than by the calendar. Endometriosis lesions outside the uterus respond to hormonal signaling wherever they sit, which is why bowel pain, painful sex, or flank pain can dominate while bleeding looks unremarkable.

Pelvic floor muscle involvement is the mechanism that gets missed most often. Months of bracing against pain trains the levator muscles to hold tension, and that tension itself becomes a pain generator — a deep, constant, achy pressure that has no cyclical pattern at all because muscles do not have cycles. It typically worsens with sitting, stress, and physical exertion, and improves with heat and deliberate relaxation.

The final category is the one to rule out rather than assume: pregnancy remains possible until you have gone twelve consecutive months without a period. Cramping with a missed period in perimenopause still warrants a pregnancy test before anything else is concluded.

Primary vs secondary dysmenorrhea: the distinction that decides your workup

ACOG's dysmenorrhea guidance divides painful periods into two categories, and the split is not academic — it determines whether the right response is symptom management or investigation.

Primary dysmenorrhea is pain produced by normal physiology. Prostaglandins released as the endometrium breaks down cause the uterus to contract, temporarily reducing blood flow to the muscle and producing the classic cramping ache. It characteristically begins within a year or two of the first period, arrives with or just before bleeding, eases as flow settles rather than dragging on through the cycle, and follows the same script every month. Nothing is structurally wrong.

Secondary dysmenorrhea is pain caused by an identifiable condition. Its signature is change: it starts later in life, or an established pattern gets worse, or the pain extends beyond the bleeding days, or new symptoms attach to it — painful sex, bowel or bladder symptoms, bleeding between periods. Perimenopause is exactly the life stage when secondary dysmenorrhea becomes the more likely explanation for significant pain, because the structural causes accumulate with age.

The practical consequence: if you had unremarkable periods through your 20s and 30s and now have severe cramping in your 40s, the working assumption should be that something has changed structurally, and the appropriate next step is a pelvic exam and usually a transvaginal ultrasound — not simply a stronger painkiller.

The structural causes that become more common in your 40s

Four conditions account for most new or worsening pelvic pain in midlife. They overlap frequently — it is common to have fibroids and adenomyosis together — which is one reason symptom patterns alone rarely settle the diagnosis.

Uterine fibroids are benign smooth-muscle tumors of the uterine wall. They tend to grow through the reproductive years and are frequently detected in the 40s. Symptoms track with size and position more than number: a fibroid distorting the uterine cavity causes heavy bleeding and cramping out of proportion to its size, while a large fibroid on the outer wall causes pressure, urinary frequency, constipation, and a bloated lower abdomen without much bleeding change. Pain can also come from a fibroid degenerating as it outgrows its blood supply — typically a more acute, localized, sometimes severe pain.

Adenomyosis is endometrial-type tissue within the muscular wall of the uterus. It produces a boggy, uniformly enlarged, tender uterus and a distinctive pain quality: deep, heavy, diffuse cramping that often starts several days before bleeding and persists through it. Heavy bleeding is common. It is underdiagnosed in part because it produces a normal-looking pelvis on casual imaging and because its symptoms are so readily attributed to "bad periods."

Endometrial polyps are focal overgrowths of the uterine lining. They are a classic cause of bleeding between periods, spotting after sex, and unpredictable bleeding patterns, and they can cause cramping as the uterus attempts to expel them. They matter beyond symptoms because a polyp is a lesion that can be sampled and removed, and because bleeding patterns in the perimenopausal years need evaluation regardless.

Endometriosis is usually thought of as a young woman's diagnosis, but it does not disappear at 40 — and long-standing disease has often produced adhesions and deep infiltrating lesions by then. Its pain profile is broader than the uterus: painful bowel movements, pain with deep penetration, cyclical flank or shoulder pain, and pain that persists between periods. Women who were told for years that they had "bad cramps" often turn out to have had endometriosis all along.

There is one more category that must stay on the list precisely because it is uncommon: ovarian pathology. Persistent bloating, early fullness after eating, and pelvic or abdominal pain that is present most days for several weeks — especially if new — is the symptom cluster that should never be filed under perimenopause without evaluation.

Pelvic pain in midlife that has nothing to do with the uterus

A meaningful share of pain labeled "perimenopause cramps" is not gynecologic. The pelvis is a crowded space, and pain from bowel, bladder, and musculoskeletal structures refers to the same region.

Irritable bowel syndrome commonly worsens around hormonal shifts, and its cramping — relieved by a bowel movement, associated with bloating and stool changes — can be nearly indistinguishable from uterine cramping. The distinguishing question is whether pain reliably changes after defecation.

Interstitial cystitis and bladder pain syndrome produce suprapubic pain and pressure that worsens as the bladder fills and eases after voiding, usually with urinary frequency and urgency in the absence of infection. A urine culture that keeps coming back negative despite persistent "UTI symptoms" is the giveaway.

Musculoskeletal sources — hip pathology, sacroiliac joint dysfunction, abdominal wall trigger points, and old surgical scars — reproduce pain with movement and specific positions rather than with cycle timing. A pain that changes with how you sit or walk but not with your cycle is unlikely to be uterine.

Genitourinary syndrome of menopause deserves separate mention. As estrogen declines, vaginal and vulvar tissue thins and loses elasticity, producing dryness, burning, urinary symptoms, and pain with sex. The NAMS 2020 position statement on genitourinary syndrome of menopause characterizes it as a progressive condition that, unlike hot flashes, does not resolve on its own. Pain with penetration in perimenopause is often tissue-related rather than deep pelvic pain, and the two need different treatments — which is why describing exactly where the pain sits matters.

Self-management ACOG supports for cramping

ACOG's dysmenorrhea guidance backs non-steroidal anti-inflammatory drugs as a first-line approach, and the timing detail is the part that most people get wrong. NSAIDs work by blocking prostaglandin production, so they are far more effective taken at the first hint of pain — or, when your cycle is predictable enough, just before it typically starts — than swallowed after cramping has peaked. Once prostaglandins have been released, you are treating pain that has already happened rather than preventing its cause.

Taking an NSAID with food, at the dose stated on the product label, on a regular schedule through the worst days generally outperforms scattered single doses. Anyone with a history of stomach ulcers, kidney disease, uncontrolled high blood pressure, asthma triggered by aspirin, or who takes blood thinners should confirm with a clinician which analgesic is appropriate.

Heat applied to the lower abdomen has genuine physiological rationale — it relaxes uterine and abdominal wall muscle and improves local blood flow — and ACOG includes it among reasonable measures. A heating pad or an adhesive heat patch worn under clothing through a workday is a practical implementation rather than a token gesture.

Regular physical activity and exercise are also part of ACOG's patient guidance. The mechanism is likely a combination of improved pelvic blood flow, endorphin release, and reduced muscle guarding. Exercise during a painful episode is worth attempting rather than avoiding on principle, though its main benefit appears to be cumulative.

Sleep, stress reduction, and limiting alcohol and nicotine belong in the same category: modest individual effects, but they alter pain perception and muscle tension, and they are within your control. What none of these measures do is change a fibroid, a polyp, or adenomyosis. If self-management is not working, that failure is diagnostic information, not a personal shortfall.

Medical options worth discussing with a clinician

When self-management is insufficient, the next tier depends entirely on the cause — which is why identifying the cause comes first.

Hormonal methods are used to make bleeding lighter and cramping milder by thinning the endometrium and, in many regimens, suppressing ovulation. Combined estrogen-progestin methods, progestin-only options, and the levonorgestrel intrauterine system are all discussed in this context. Estrogen-free oral contraception also exists: the drospirenone-only pill, whose FDA prescribing information dates from 2019, is approved as a contraceptive and its label sets out a 24-active/4-inactive-tablet regimen — it is not labeled as a treatment for cramping. Estrogen-containing methods are not appropriate for everyone in midlife — smoking, migraine with aura, high blood pressure, and clot history all change the calculus — so the choice is genuinely individual.

For fibroids and adenomyosis, options extend to procedures: hysteroscopic removal of cavity-distorting fibroids or polyps, uterine artery embolization, endometrial ablation for bleeding, myomectomy, and hysterectomy. These differ substantially in recovery, effect on fertility, and durability, and are worth discussing as a set rather than one at a time.

Menopausal hormone therapy is a different intervention with a different purpose. The 2022 NAMS hormone therapy position statement addresses hormone therapy for vasomotor symptoms, genitourinary symptoms, and bone protection, with individualized assessment of benefits and risks by age and time since menopause. It is not a treatment for fibroid or adenomyosis pain, and it is a common point of confusion when women in perimenopause are offered hormone therapy for hot flashes and expect it to resolve cramping.

Pelvic floor physical therapy is under-used and frequently the missing piece when pain has become chronic, constant, and non-cyclical. It targets the muscular component that persists after — or alongside — the original driver.

This site does not sell or prescribe anything. If you want to see which telehealth and in-person providers handle perimenopausal pain and bleeding evaluation, compare providers and bring the questions below to whichever one you choose.

Pain patterns that warrant evaluation rather than reassurance

"Just perimenopause" is the phrase that delays diagnosis. Some patterns are simply not explained by the menopause transition, and recognizing them is the single most useful thing this page can give you.

Pain that is escalating month over month. Perimenopausal irregularity fluctuates; it does not follow a steady upward trajectory. A clear worsening trend across many cycles points to something growing or progressing.

Pain that is consistently one-sided. The uterus sits in the midline, and uterine cramping is felt centrally. Persistent pain fixed on one side directs attention to an ovary, a tube, a lateral fibroid, or a non-gynecologic structure.

Pain that no longer tracks with your cycle at all. Once pain becomes continuous and untethered from bleeding, a purely hormonal explanation becomes less likely and structural or musculoskeletal causes rise.

Pain that stopped responding to what used to work. NSAIDs losing effectiveness after years of adequate control is a change in the underlying condition, not tolerance.

Pain accompanied by bloating, early fullness after small meals, unexplained weight change, or a change in bowel or bladder habits present most days for several weeks. This combination requires evaluation on a short timeline, not at your next annual visit.

Pain that keeps you from work, sleep, or normal activity for any part of the month. Functional impact is a legitimate clinical threshold in its own right, independent of any imaging finding. If pain is organizing your calendar, that is sufficient reason to be evaluated.

The bleeding red flags that travel alongside pain

Cramping and abnormal bleeding are often the same problem presenting twice, and ACOG's patient guidance on perimenopausal bleeding and bleeding after menopause identifies the bleeding patterns that need evaluation. Applied to someone whose main complaint is pain, these are the accompanying features that raise the priority.

Bleeding between periods and bleeding after sex are both listed by ACOG as reasons to be evaluated. Polyps, fibroids distorting the cavity, cervical lesions, and endometrial changes all present this way, and each requires a different response.

Bleeding that is very heavy — soaking through a pad or tampon hourly, passing large clots, or bleeding that forces you to change protection overnight — should be evaluated rather than endured, and heavy bleeding also drives iron deficiency, which produces its own fatigue and breathlessness that get mislabeled as perimenopause symptoms.

Periods lasting substantially longer than usual, or cycles arriving less than three weeks apart, are pattern changes worth reporting rather than tracking silently for another year.

Any bleeding after menopause — that is, after twelve consecutive months without a period — needs evaluation, without exception and without waiting to see whether it repeats. ACOG is unambiguous on this, and the ACOG committee opinion on transvaginal ultrasonography sets out how endometrial thickness measurement is used in evaluating postmenopausal bleeding. Most causes turn out to be benign; the point of evaluating promptly is to identify the minority that are not, at a stage when they are most treatable.

One distinction worth knowing: incidental endometrial thickening found on a scan done for another reason, in a woman with no bleeding, is a different situation from thickening in a woman who is bleeding. The 2024 SOGC guideline addresses asymptomatic endometrial thickening in postmenopausal women specifically, and it is not managed identically to bleeding-associated findings. If a scan report has alarmed you, ask which situation applies to you.

What a proper evaluation usually involves

Knowing the likely sequence removes a lot of anxiety and makes it easier to tell whether your concern is being taken seriously.

It starts with history and a pelvic exam. The exam is more informative than most people expect: a uniformly enlarged, tender uterus suggests adenomyosis; an irregularly enlarged, firm, lumpy uterus suggests fibroids; focal tenderness on one side or on specific pelvic muscles points elsewhere. A clinician who can reproduce your pain by pressing on a specific muscle has learned something a scan will not show.

Transvaginal ultrasound is the standard first imaging step. It shows fibroid number, size and location, features suggesting adenomyosis, ovarian cysts and masses, and endometrial thickness. ACOG's committee opinion on transvaginal ultrasonography describes its role in evaluating the endometrium in women with postmenopausal bleeding.

Saline infusion sonography or hysteroscopy may follow when a polyp or a cavity-distorting fibroid is suspected — both give a far better view of the uterine cavity than plain ultrasound, and hysteroscopy allows removal in the same setting in many cases.

Endometrial sampling — a brief office biopsy — is used to evaluate the lining directly when bleeding is abnormal, when imaging is inconclusive, or when risk factors warrant it. It is uncomfortable but brief, and taking an NSAID beforehand is usually advised.

Bloodwork typically includes a complete blood count to detect anemia from heavy bleeding, ferritin to assess iron stores, a pregnancy test where relevant, and thyroid testing, since thyroid dysfunction produces bleeding changes and fatigue that mimic the transition. Hormone levels such as FSH are of limited value in perimenopause because they fluctuate widely from week to week; a single value rarely changes management.

Tracking that makes your appointment worth attending

A couple of months of specific records will do more for your diagnosis than any single symptom description, because the pattern is the diagnostic information and pattern is exactly what memory distorts.

Record the dates bleeding starts and stops, and rate the flow concretely — number of pads or tampons per day, whether you passed clots and roughly how large, whether you soaked through protection or bled through onto clothing or bedding. "Heavy" means different things to different people; product counts do not.

Record pain separately from bleeding, with a 0-to-10 rating, the days it occurs, where it sits, and what it feels like — cramping, pressure, burning, stabbing. The key column is the relationship between pain days and bleeding days, since pain that precedes or outlasts bleeding is the pattern that suggests adenomyosis or endometriosis.

Note what you took, at what dose and what time, and whether it helped. "NSAIDs don't work for me" and "I take two ibuprofen once the pain is already bad" are entirely different clinical statements.

Note the associated symptoms that are easy to forget in an appointment: pain with sex and whether it is at entry or deep, bowel and bladder changes, bloating, fatigue, and any day you missed work or cancelled plans. Days lost are a metric clinicians act on.

Bring it written down or on your phone. A one-page log converts a vague conversation into a specific one, and it is the most reliable defense against having a real problem filed under "just perimenopause."

What happens to cramps after menopause

Once you have gone twelve consecutive months without a period, menstrual cramping ends, because there is no longer a cycle to produce it. Fibroids generally shrink after menopause as estrogen falls, and adenomyosis symptoms typically subside as well. For many women with cycle-driven pain, this is a genuine and permanent resolution.

What this makes clinically significant is any pelvic pain that persists or appears after menopause. It cannot be attributed to menstruation, so it needs its own explanation — pelvic floor dysfunction, genitourinary syndrome of menopause, bowel or bladder conditions, adhesions from prior surgery, or, less commonly, something that requires prompt attention. Post-menopausal pelvic pain should never be dismissed as leftover perimenopause.

Postmenopausal bleeding is the sharper rule: it always needs evaluation, whatever the volume and however briefly it lasted. ACOG's guidance is explicit on this point, and a single episode of spotting counts.

If you are still in the transition, the practical takeaway is that waiting it out is a reasonable strategy only for pain that is stable, cycle-linked, and manageable. It is not a strategy for pain that is escalating, one-sided, continuous, or accompanied by the bleeding patterns ACOG flags. Those need a name before they need a plan.

Questions to ask your clinician

Bring these to your appointment — they turn a vague visit into a decision.

• My cramps have gotten steadily worse — could this be secondary dysmenorrhea rather than normal perimenopause, and what would we do to find out?
• Can we do a pelvic exam and a transvaginal ultrasound to check for fibroids, adenomyosis, or polyps before we treat this as a hormone issue?
• My pain starts several days before I bleed and continues after it stops — does that pattern point toward adenomyosis or endometriosis?
• I'm bleeding between periods as well as cramping. Does that change what evaluation I need, and do I need endometrial sampling?
• I've been taking NSAIDs and they used to work but don't anymore. What does that tell you, and what are my next options?
• My pain is constant and no longer tied to my cycle at all. Could my pelvic floor muscles be involved, and would pelvic floor physical therapy help?
• If we do find fibroids or adenomyosis, can you walk me through all the options at once — hormonal, procedural, and surgical — so I can compare recovery time and how long each lasts?

Frequently asked questions

Can you have cramps in perimenopause without a period?

Yes, and it is common. Ovulation itself causes a one-sided ache as the follicle ruptures, and an anovulatory cycle can produce uterine contractions without visible bleeding. Structural causes are period-independent by nature: adenomyosis aches through the month, fibroids cause pressure and cramping determined by size and position rather than the calendar, and endometriosis pain often has no relationship to bleeding. Cramping without a period is concerning when it is new and persistent, consistently one-sided, escalating month over month, or accompanied by fever, abnormal bleeding, or bloating with early fullness. Pregnancy is still possible until twelve consecutive months without a period, so a pregnancy test comes first when a period is genuinely missed.

Why did my cramps suddenly get worse in my 40s after decades of easy periods?

Because pain that begins or worsens in the 40s is usually secondary dysmenorrhea — pain from an underlying condition — rather than the primary dysmenorrhea that starts in adolescence and stays stable. ACOG's dysmenorrhea guidance separates the two on exactly this basis. Fibroids, adenomyosis, and endometrial polyps all become more common with age, and anovulatory cycles allow the lining to build thicker before shedding, producing heavier bleeding, more clot passage, and stronger contractions. New severe cramping in midlife warrants a pelvic exam and usually a transvaginal ultrasound rather than only a stronger painkiller.

How do I tell fibroid pain from adenomyosis pain?

Often you cannot from symptoms alone, which is why imaging exists — and the two frequently coexist. Fibroids more typically cause pressure, a heavy or bloated lower abdomen, urinary frequency, and constipation, with an irregularly enlarged, firm uterus on exam. Adenomyosis more typically causes deep, diffuse, boggy cramping that begins several days before bleeding and continues through it, with a uniformly enlarged and tender uterus. Both commonly cause heavy bleeding. A pelvic exam plus transvaginal ultrasound is the usual first step to distinguish them, and treatment differs enough that the distinction matters.

Is it normal for perimenopause cramps to be worse than my periods ever were?

Increased cramping is common in perimenopause because anovulatory cycles produce heavier, more disorganized shedding. But "common" is not the same as "requires no evaluation." Cramping that is severe enough to interrupt work or sleep, that has worsened steadily across many cycles, or that no longer responds to NSAIDs that used to work has crossed from expected variation into a pattern that should be investigated. Functional impact is a legitimate reason to be evaluated on its own, independent of how any imaging turns out.

What actually helps perimenopause cramps at home?

ACOG's dysmenorrhea guidance supports NSAIDs, and the timing matters: they block prostaglandin production, so taking them at the first sign of pain — or just before pain typically starts, if your cycle is predictable — works substantially better than taking them after cramping peaks. Heat applied to the lower abdomen relaxes uterine and abdominal muscle and is included in ACOG's patient guidance, as is regular exercise. Anyone with ulcers, kidney disease, uncontrolled hypertension, or who takes blood thinners should confirm which analgesic is appropriate. If these measures are no longer working, that is diagnostic information worth reporting rather than a reason to try harder.

Can perimenopause cause pelvic pain that isn't cramping at all?

Yes, and the alternative sources are frequently missed. Pelvic floor muscle dysfunction produces constant deep aching with no cyclical pattern, worse with sitting and exertion, often developing after months of guarding against period pain. Genitourinary syndrome of menopause causes burning, dryness, and pain with sex from tissue thinning; the NAMS 2020 position statement describes it as progressive and unlikely to resolve without treatment. Irritable bowel syndrome, interstitial cystitis, and hip or sacroiliac problems all refer pain to the same region. If your pain changes with bowel movements, bladder filling, or how you sit rather than with your cycle, it is probably not uterine.

When does cramping in perimenopause become an emergency?

Seek urgent care for sudden severe pelvic pain, especially one-sided, that comes on abruptly and does not ease — this can indicate ovarian torsion, a ruptured cyst, or a degenerating fibroid. Also seek urgent care for pelvic pain with fever or chills, which suggests infection; for bleeding heavy enough to soak through a pad or tampon every hour for several hours; and for pain with fainting, severe dizziness, or vomiting you cannot keep down. If pregnancy is possible, sudden one-sided pain with any bleeding needs same-day assessment to exclude ectopic pregnancy.

Will hormone therapy stop my perimenopause cramps?

Not reliably, because it treats a different problem. The 2022 NAMS hormone therapy position statement addresses hormone therapy for vasomotor symptoms, genitourinary symptoms, and bone protection, with individualized assessment of risks and benefits by age and time since menopause. It is not a treatment for fibroid or adenomyosis pain. Approaches aimed at cramping and heavy bleeding instead work by suppressing or thinning the endometrium — combined hormonal contraception, progestin-only options, or a levonorgestrel IUD. Estrogen-free oral contraception exists as well: the drospirenone-only pill is approved as a contraceptive, and its FDA prescribing information sets out a 24-active/4-inactive regimen. Which option fits depends on the cause and on your cardiovascular and migraine history, so this is a conversation with a clinician.

Do cramps stop after menopause?

Menstrual cramping ends once you have gone twelve consecutive months without a period, because the cycle that drives it has ended. Fibroids generally shrink as estrogen falls and adenomyosis symptoms usually subside. That is precisely why pelvic pain that persists or newly appears after menopause needs its own explanation rather than being attributed to leftover perimenopause — and why any bleeding after menopause requires evaluation, without exception. ACOG's guidance treats postmenopausal bleeding as always warranting assessment, including a single episode of spotting.

My scan showed a thickened lining but I'm not bleeding — should I worry?

That is a different clinical situation from thickening found in someone who is bleeding, and it is not managed the same way. The 2024 SOGC guideline addresses asymptomatic endometrial thickening in postmenopausal women specifically, while ACOG's committee opinion on transvaginal ultrasonography covers the role of endometrial thickness measurement in evaluating women who have postmenopausal bleeding. Ask your clinician which of the two categories your finding falls into, whether the measurement was technically adequate, and what the recommended follow-up interval is — those three questions usually resolve the uncertainty.

Primary sources

1. ACOG: Dysmenorrhea — Painful Periods (patient FAQ)
2. ACOG: The Menopause Years (patient FAQ)
3. ACOG: Perimenopausal Bleeding and Bleeding After Menopause (patient FAQ)
4. ACOG Committee Opinion: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding
5. Guideline No. 451: Asymptomatic Endometrial Thickening in Postmenopausal Women. J Obstet Gynaecol Can, 2024. PMID 38901794
6. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 2022. PMID 35797481
7. The 2020 genitourinary syndrome of menopause position statement of NAMS. Menopause, 2020. PMID 32852449
8. FDA prescribing information, Slynd (drospirenone) 4 mg tablets, 2019